BONE-MARROW TRANSPLANTATION (BMT) FOR WISKOTT-ALDRICH SYNDROME (WAS) - COMPARISON OF UNRELATED DONOR (URD) BMT WITH RESULTS OF BMT USING MATCHED SIBLING DONORS (MSD) AND OTHER RELATED DONORS (ORD)

被引：0
|
作者：
FILIPOVICH, AH
KOLLMAN, C
ROWLINGS, P
HOROWITZ, M
机构：
[1] UNIV MINNESOTA,MINNEAPOLIS,MN 55455
[2] NATL MARROW DONOR PROGRAM,ST PAUL,MN
[3] INT BONE MARROW TRANSPLANT REGISTRY,MILWAUKEE,WI
来源：
EXPERIMENTAL HEMATOLOGY | 1994年 / 22卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：679 / 679
页数：1
相关论文
共 50 条
  • [41] SECONDARY SYSTEMIC IMMUNOSUPPRESSANTS (SSI) AFTER MYELOABLATIVE HLA MATCHED RELATED AND UNRELATED BONE MARROW TRANSPLANTATION (BMT) USING HIGH DOSE CYCLOPHOSPHAMIDE (HICY) AS SOLE GVHD PROPHYLAXIS
    Durakovic, N.
    Meade, Bolanos J.
    Zahurak, M.
    Kowalski, J.
    Fuchs, E. J.
    Jones, R. J.
    Luznik, L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S161 - S162
  • [42] Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor
    Chim, C. S.
    Lie, A. K. W.
    Liang, R.
    Au, W. Y.
    Kwong, Y. L.
    BONE MARROW TRANSPLANTATION, 2007, 40 (04) : 339 - 347
  • [43] Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor
    C S Chim
    A K W Lie
    R Liang
    W Y Au
    Y L Kwong
    Bone Marrow Transplantation, 2007, 40 : 339 - 347
  • [44] HLA Matched Sibling Donor (MSD) Bone Marrow Transplantation (BMT) for Children with Limited Financial Resources in a Government Hospital (Maharaja Yashwantrao Holker Hospital [MYH]) in Indore, India: A Collaborative Project between East and West.
    Malpani, Preeti
    Chaudhary, Prachi
    Choubey, Dharmanshu
    Joshi, Swati
    Purohit, Manish
    Yadav, Ashok
    Lahoti, Brijesh
    Tripathi, Amrita
    Mandloi, Rashika
    Chanderi, Sachin
    Arora, K. K.
    Mutha, Anita
    Satwani, Prakash
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S216 - S217
  • [45] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA USING SIBLING AND VOLUNTEER UNRELATED DONORS - A COMPARISON OF COMPLICATIONS IN THE 1ST 2 YEARS
    MARKS, DI
    CULLIS, JO
    WARD, KN
    LACEY, S
    SZYDLO, R
    HUGHES, TP
    SCHWARER, AP
    LUTZ, E
    BARRETT, AJ
    HOWS, JM
    BATCHELOR, JR
    GOLDMAN, JM
    ANNALS OF INTERNAL MEDICINE, 1993, 119 (03) : 207 - 214
  • [46] COMPARISON OF HLA CLASS-II TYPING RESULTS FOR CHINESE BONE-MARROW TRANSPLANT PATIENTS AND THEIR MATCHED UNRELATED DONORS USING SEROLOGICAL AND MOLECULAR TECHNIQUES
    DUNBAR, MM
    HAWKINS, BR
    HUMAN IMMUNOLOGY, 1993, 37 : 84 - 84
  • [47] Preemptive donor leukocyte infusions (DLI) to prevent relapse in patients (PTS) with high risk hematological malignancies undergoing bone marrow transplant (BMT) using partially mismatched related donors (PMRD)
    Pati, AR
    Godder, K
    Abhyankar, S
    Parrish, R
    Lamb, L
    Gee, AP
    HensleeDowney, PJ
    BLOOD, 1995, 86 (10) : 2243 - 2243
  • [48] Reduced intensity conditioning (RIC) with cladribine, busulfan and 4 gy total body irradiation (TBI) for bone marrow transplantation (BMT) from an HLA-matched unrelated donor (URD): A prospective multi-institutional clinical trial.
    Kim, Sung-Won
    Hino, Masayuki
    Hatanaka, Kazuo
    Ueda, Yasunori
    Tanosaki, Ryuji
    Hirokawa, Makoto
    Mori, Shin-ichiro
    Nakase, Kazunori
    Ito, Toshiro
    Shimazaki, Chihiro
    Kawai, Yasukazu
    Sunami, Kazutaka
    Nakamae, Hirohisa
    Tamaki, Toshiharu
    Mizutani, Chisato
    Kami, Masahiro
    Fukuda, Takahiro
    Tajima, Kinuko
    Nagafuji, Koji
    Taniguchi, Shuichi
    Takaue, Yoichi
    Harada, Mine
    BLOOD, 2006, 108 (11) : 443B - 443B
  • [49] Hematopoietic Bone Marrow Transplantation (BMT) for Patients with High-Risk Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), or Myelodysplastic Syndrome (MDS) Using HLA-Haploidentical Related Donors: A Trial Using Radiolabeled Anti-CD45 Antibody Combined with Immunosuppression Before and After BMT
    Mawad, Raya
    O'Donnell, Paul
    Gooley, Ted A.
    Rajendran, Joseph G.
    Fisher, Darrell R.
    Gopal, Ajay K.
    Deeg, H. Joachim
    Shields, Andrew
    Green, Damian J.
    Maloney, David G.
    Sandmaier, Brenda M.
    Storb, Rainer
    Appelbaum, Frederick R.
    Press, Oliver W.
    Pagel, John M.
    BLOOD, 2012, 120 (21)
  • [50] Low-dose (550 cGy), single exposure total body irradiation (TBI) and cyclophosphamide as conditioning for unrelated donor (URD) bone marrow transplant (BMT) results in consistent donor cell engraftment without fatal regimen-related toxicity (RROT).
    Girgis, M
    Brown, RA
    Khoury, H
    Hallemeier, C
    Zehnbauer, B
    Goodnough, LT
    Westervelt, P
    Vij, R
    Blum, W
    Lin, HS
    DiPersio, JF
    Adkins, DR
    BLOOD, 2001, 98 (11) : 478A - 479A
12345